GGrantIndex
← Leaderboards

Samia J. Khoury

Brigham And Women'S Hospital

$10,360,565
Attributed
$10,360,565
Total exposure
14
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2M · FY200515
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$15,982,854 · 15

By mechanism

R01$8,566,626 · 4
U19$5,803,516 · 2
R56$1,210,525 · 2
R21$265,287 · 1
R29$116,900 · 1
R13$20,000 · 1

Top collaborators

No co-investigators on record.

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Multiple Sclerosis

Research focus

Multiple SclerosisCytokineImmunotherapyNeuraxisInflammatoryIn VitroAnimal ModelCellsExperimental Autoimmune EncephalomyelitisIn VivoClinical ResearchInflammationHuman SubjectMyelinRelapseMediatingChronic DiseaseMigrationImmuneResistancePathogenesisRegulationT-LymphocytePathway Interactions

Grant awards (53)

Immune Regulation of Neural Stem Cell Program in EAE$393,263
R01 · FY2015 · AI · contact PI
Immune Regulation of Neural Stem Cell Program in EAE$393,263
R01 · FY2014 · AI · contact PI
Immune Regulation of Neural Stem Cell Program in EAE$369,667
R01 · FY2013 · AI · contact PI
Neural Stem Cells and Regulatory T Cells$406,654
R56 · FY2012 · AI · contact PI
Immune Regulation of Neural Stem Cell Program in EAE$393,263
R01 · FY2012 · AI · contact PI
MEMORY T CELLS IN EAE$387,391
R01 · FY2012 · AI · contact PI
11th International Congress of Neuroimmunology$20,000
R13 · FY2012 · NS · contact PI
Immune Regulation of Neural Stem Cell Program in EAE$393,035
R01 · FY2011 · AI · contact PI
MEMORY T CELLS IN EAE$387,391
R01 · FY2011 · AI · contact PI
Role and mechanism of negative costimulatory pathways in EAE$402,588
R56 · FY2010 · AI · contact PI
MEMORY T CELLS IN EAE$391,304
R01 · FY2010 · AI · contact PI
Impact of IFN-gamma on Neural Stem Cell Repair Potential in EAE$323,436
R01 · FY2010 · AI · contact PI
Impact of IFN-gamma on Neural Stem Cell Repair Potential in EAE$431,555
R01 · FY2009 · AI · contact PI
Role and mechanism of negative costimulatory pathways in EAE$401,283
R56 · FY2009 · AI · contact PI
MEMORY T CELLS IN EAE$395,256
R01 · FY2009 · AI · contact PI
MEMORY T CELLS IN EAE$395,256
R01 · FY2008 · AI · contact PI
Impact of IFN-gamma on Neural Stem Cell Repair Potential in EAE$326,703
R01 · FY2008 · AI · contact PI
Treatment of Autoimmune Disease by Costimulatory Signal*$872,867
U19 · FY2007 · AI · contact PI
Impact of IFN-gamma on Neural Stem Cell Repair Potential in EAE$333,031
R01 · FY2007 · AI · contact PI
Role and Mechanism of PDI-PDL Pathway in EAE$304,191
R01 · FY2007 · AI · contact PI
Immune Regulation of Neural Stem Cell Program In EAE$279,275
R01 · FY2007 · AI · contact PI
Administrative Core$181,227
U19 · FY2007 · AI · contact PI
Treatment of Autoimmune Disease by Costimulatory Signal*$849,008
U19 · FY2006 · AI · contact PI
Role and Mechanism of PDI-PDL Pathway in EAE$313,276
R01 · FY2006 · AI · contact PI
Immune Regulation of Neural Stem Cell Program In EAE$287,616
R01 · FY2006 · AI · contact PI
Treatment of Autoimmune Disease by Costimulatory Signal*$848,005
U19 · FY2005 · AI
Role and Mechanism of PDI-PDL Pathway in EAE$320,815
R01 · FY2005 · AI
Immune Regulation of Neural Stem Cell Program In EAE$294,538
R01 · FY2005 · AI
Treatment of Autoimmune Disease by Costimulatory Signal*$859,049
U19 · FY2004 · AI
Role and Mechanism of PDI-PDL Pathway in EAE$320,815
R01 · FY2004 · AI
Immune Regulation of Neural Stem Cell Program In EAE$294,538
R01 · FY2004 · AI
Treatment of Autoimmune Disease by Costimulatory Signal*$432,118
U19 · FY2003 · AI
COSTIMULATORY REGULATION OF TH1/TH2 CYTOKINES IN EAE$218,304
R01 · FY2003 · AI
AUTOIMMUNITY: TREATMENT BY COSTIMULATORY SIGNAL BLOCKADE$428,260
U19 · FY2002 · AI
Immunoregulation in EAE and novel costimulatory pathways$265,287
R21 · FY2002 · AI
COSTIMULATORY REGULATION OF TH1/TH2 CYTOKINES IN EAE$212,614
R01 · FY2002 · AI
EFFECT OF ORAL PROVENTIL ON IL 12 SECRETION BY MONOCYTES IN MS PATIENTS$0
M01 · FY2002 · RR
TREATMENT OF MULIPLE SCLEROSIS BY ORAL TOLERIZATION TO MYELIN ANTIGEN$0
M01 · FY2002 · RR
MYCOPHENOLATE MOFETIL IN TRANSITIONAL MULTIPLE SCLEROSIS$0
M01 · FY2002 · RR
IMMUNOREACTIVITY TO MYORAL TREATMENT IN EARLY RELAPSING-REMITTING MS PATIENTS$0
M01 · FY2002 · RR
AUTOIMMUNITY: TREATMENT BY COSTIMULATORY SIGNAL BLOCKADE$676,340
U19 · FY2001 · AI
COSTIMULATORY REGULATION OF TH1/TH2 CYTOKINES IN EAE$206,423
R01 · FY2001 · AI
IMMUNOREACTIVITY TO MYORAL TREATMENT IN EARLY RELAPSING-REMITTING MS PATIENTS$0
M01 · FY2001 · RR
TREATMENT OF MULIPLE SCLEROSIS BY ORAL TOLERIZATION TO MYELIN ANTIGEN$0
M01 · FY2001 · RR
MYCOPHENOLATE MOFETIL IN TRANSITIONAL MULTIPLE SCLEROSIS$0
M01 · FY2001 · RR
EFFECT OF ORAL PROVENTIL ON IL 12 SECRETION BY MONOCYTES IN MS PATIENTS$0
M01 · FY2001 · RR
AUTOIMMUNITY: TREATMENT BY COSTIMULATORY SIGNAL BLOCKADE$656,642
U19 · FY2000 · AI
COSTIMULATORY REGULATION OF TH1/TH2 CYTOKINES IN EAE$200,407
R01 · FY2000 · AI
IMMUNOREGULATION IN EAE--ROLE OF T CELL COSTIMULATION$116,900
R29 · FY2000 · AI
EFFECT OF ORAL PROVENTIL ON IL 12 SECRETION BY MONOCYTES IN MS PATIENTS$0
M01 · FY2000 · RR
TREATMENT OF MULIPLE SCLEROSIS BY ORAL TOLERIZATION TO MYELIN ANTIGEN$0
M01 · FY2000 · RR
MYCOPHENOLATE MOFETIL IN TRANSITIONAL MULTIPLE SCLEROSIS$0
M01 · FY2000 · RR
IMMUNOREACTIVITY TO MYORAL TREATMENT IN EARLY RELAPSING-REMITTING MS PATIENTS$0
M01 · FY2000 · RR